TITLE

Topiramate withdrawal

PUB. DATE

June 2007

SOURCE

Reactions Weekly;6/2/2007, Issue 1154, p22

SOURCE TYPE

Periodical

DOC. TYPE

Case Study

ABSTRACT

The article presents a case report of an obese man who experienced rebound weight gain following topiramate withdrawal. The man had a body mass index of 32 and a history of multiple dietary treatments followed by weight gain and an unsuccessful orlistat treatment. The man stopped further treatment with topiramate and started Cognitive Behavior Therapy. A brief commentary is presented.

ACCESSION #

25497988

 

Related Articles

• SECTION 7 METABOLIC DISORDERS.  // MPR - Pharmacist's Edition;Fall2014, Vol. 8 Issue 3, p131 

  The article offers information on several drugs for the treatment of obesity. The Belviq weight-loss medication from pharmaceutical firm Eisai Co. Ltd. should be used together with a reduced-calorie diet and weight maintenance to treat obesity. Obese patients are advised to take the Qsymia...

• Review of the pharmacologic arsenal for the war on obesity. Derbyshire, Mary Beth; Shek, Allen; Szkotak, Jonathan // Formulary;Apr2013, Vol. 48 Issue 4, p136 

  Obesity has become a highly prevalent chronic condition that is associated with significant morbidity and mortality. Studies have demonstrated that even as little as 5% to 10% of weight loss is associated with an improvement in cardiovascular risk factors and a reduction in the incidence of type...

• The uphill battle facing antiobesity drugs. Daubresse, M; Alexander, G C // International Journal of Obesity;Mar2015, Vol. 39 Issue 3, p377 

  The authors reflect on the limited adoption of antibobesity drugs in clinical practice in the U.S. despite their association with short-term weight loss. They cite several antiobesity drugs that were withdrawn from the market due to the occurrence of adverse effects including sibutramine and...

• Orlistat.  // Reactions Weekly;11/10/2012, Issue 1427, p35 

  The article describes two cases of male patients who developed oral aphthous ulcers while undergoing orlistat therapy.

• Topiramate.  // Reactions Weekly;9/22/2012, Issue 1420, p46 

  The article describes three case reports of anorexia in children with moderate or severe mental retardation induced by topiramate therapy for symptomatic Lennox-Gastaut syndrome.

• Topiramate.  // Reactions Weekly;9/22/2012, Issue 1420, p47 

  The article describes the case of a 31-year-old man who experienced erectile dysfunction during topiramate therapy for the treatment of encephalitis with seizures.

• Topiramate/valproate.  // Reactions Weekly;Mar2015, Vol. 1544 Issue 1, p222 

  The article presents case report of a man in his twenties who developed general weakness and nausea while receiving topiramate.

• Weight-Loss Aid Alert. Calechman, Steve // Natural Health;Dec2002, Vol. 32 Issue 9, p24 

  Reports on the warning of U.S. Food and Drug Administration against using two Chinese weight-loss supplements Chasu Jianfei Diet Capsules and Chasu Gempi due to health problems in Japan.

• Chinese slimming capsules poisoning people.  // Asian Pacific Post;4/16/2009, p10 

  The article reveals the side effects and serious health problems caused by Chinese slimming capsules available on the Internet.

Read the Article